Sign in
Not yet taking people in United StatesPhase 4

Low-dose ketamine for sickle cell pain crises in children seen in the emergency room

Tests ketamine against opioids for sickle cell pain in children and young people.

Key facts

Who runs it
University of Mississippi Medical Center
Where
Jackson, United StatesSee the site
Trial code
Registry title
Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis
Status
Not yet recruiting
Phase
Phase 4
People taking part
400 people, planned
Started
1 Aug 2026
Expected to end
1 Oct 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Standardized Low-dose bolus IV Ketamine within 30 minutes of arrival and every 1 hour as needed for max of 3 doses.
  • Standard Care (in control arm)
Record updated
6 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people with sickle cell disease who come to the emergency department with a pain crisis.

Age
2 Years to 21 Years
Sex
All sexes can join.
Disease stage
Confirmed sickle cell disease of any genotype, with a vaso-occlusive (pain) crisis at the emergency department.
Earlier treatment
No ketamine use in the previous 24 hours.

Main reasons for not taking part

  • Allergy to ketamine
  • Severe agitation or psychosis
  • Pregnancy
  • Unstable blood circulation, as judged by the physician
  • Pain not caused by a vaso-occlusive crisis (for example fever, acute chest syndrome, stroke, injury)

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Confirmed Sickle Cell Disease (any genotype), Presenting to the Emergency Department with Vaso-occlusive crisis/pain crisis, Consent obtained

Who cannot take part

  • Ketamine allergy, Severe agitation/psychosis, Pregnancy, Hemodynamic instability (as judged by physician), Increased intracranial pressure, Severe hepatic impairment, Ketamine use within the previous 24 hours, Presentation for non-VOC-related pain (i.e. fever, acute chest syndrome, stroke, traumatic injuries etc)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 21 years old?

Where in United States

  • University of Mississippi Medical Center, Pediatric Emergency DepartmentJackson, United StatesContact: Cynthia Karlson, Ph.D.Not yet recruiting

About the trial

What the trial wants to find out

The goal of this study is to learn if Ketamine works more efficiently, as compared to Opioids, for Sickle Cell Pain The main questions it aims to answer are:

Read full original descriptionShow less

Does Ketamine lower the number of times participants need to be admitted for continued pain control during a Sickle Cell Pain Crisis.

Does Ketamine decrease the amount of time it takes to reach adequate pain control/pain score improvement, as compared to Opioids.

Patients could have too low or too high blood pressure or sleepiness. Researchers will compare Ketamine to Opioids (Morphine or Dilaudid) to see if Ketamine works to treat pain enough that you do not need to be admitted to the hospital.

Participants will:

On arrival to the Children's ER for Sickle Cell Pain crisis will get Ketamine, instead of Morphine or Dilaudid, along with the typical Tylenol, Toradol, Lidocaine patch for pain control while in the ER.

During this time we will follow your reported pain scale (0-10) to monitor your pain response to the Ketamine, as well as follow rate of hospital admission.

The 2 groups in the trial

  • Any patient with confirmed Sickle Cell Disease in pain crisis.Treatment being tested

    This group will be any patient, aged 2 years until 21 years with confirmed sickle cell disease who presents to the Pediatric Emergency Department with Pain will receive multimodal pain control using Acetaminophen, Toradol, lidocaine patch, and heat packs, as well as IV Ketamine in place of Opioids.

    Treatment: Standardized Low-dose bolus IV Ketamine within 30 minutes of arrival and every 1 hour as needed for max of 3 doses.

  • Retrospective Historical Control GroupOther group

    Treatment: Standard Care (in control arm)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of a Standardized Low-Dose Bolus Ketamine Pathway for Management of Pediatric Sickle Cell Patients Presenting to the Emergency Department With Pain
Plain-language title
Low-dose ketamine for sickle cell pain crises in children seen in the emergency roomGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07682662, who can take part
Record updated
6 July 2026